0001543256-24-000001.txt : 20240410 0001543256-24-000001.hdr.sgml : 20240410 20240410141613 ACCESSION NUMBER: 0001543256-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 EFFECTIVENESS DATE: 20240410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunomic Therapeutics, Inc. CENTRAL INDEX KEY: 0001543256 ORGANIZATION NAME: IRS NUMBER: 203878827 STATE OF INCORPORATION: DE FISCAL YEAR END: 1212 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-510234 FILM NUMBER: 24835314 BUSINESS ADDRESS: STREET 1: ATTN: WILLIAM HEARL, 15010 BROSCHART RD. STREET 2: SUITE 250 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-728-0860 MAIL ADDRESS: STREET 1: ATTN: WILLIAM HEARL, 15010 BROSCHART RD. STREET 2: SUITE 250 CITY: ROCKVILLE STATE: MD ZIP: 20850 D 1 primary_doc.xml X0708 D LIVE 0001543256 Immunomic Therapeutics, Inc. ATTN: C. Eric Winze, 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 301-968-3509 DELAWARE None None Corporation true Dong-Gun Kim 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Executive Officer Director C. ERIC WINZER 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Executive Officer Robert Ahlgren 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director Steve Park 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director Ki-Hong Ahn 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director Matthew Chang 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director Michael Lack 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director Ronald Thiboutot 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director James Wishart 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director Yang Gon Jin 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director Biotechnology Decline to Disclose 06b false 2024-01-30 true true false 0 20900000 3000000 17900000 false 1 0 0 0 false Immunomic Therapeutics, Inc. C. Eric Winzer C. Eric Winzer Chief Financial Officer 2024-04-10